---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000058"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-07-15T10:01:33+00:00"
generated_at: "2026-07-15T10:10:14.996774+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q2 2026 EPS beats; raises full-year adjusted EPS guidance to at least $27.00

## Summary
- Operating revenue $49.8B (+0.8% YoY); diluted EPS $6.71, adjusted diluted EPS $7.45 (includes ~$0.80 net below-the-line benefit).
- FY 2026 GAAP EPS guidance raised to at least $20.10; adjusted EPS guidance raised to at least $27.00.
- Operating cash flow guidance raised to at least $6.0B; Q2 operating cash flow $1.9B.
- Health Benefits segment operating margin fell to 2.1% from 3.8% YoY; medical membership ~44.9M, down 469K sequentially.
- Quarterly dividend declared $1.72 per share, payable Sept 25, 2026 to holders of record Sept 10, 2026.

## SEC filing metadata
- accession: 0001156039-26-000058
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-07-15T10:01:33+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/0001156039-26-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/elv-20260715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000058
- JSON: https://secwatch.observer/filing/0001156039-26-000058.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.